ASPEN AEROGELS INC
Business
ASPEN AEROGELS INC designs, develops and manufactures high-performance aerogel materials for industrial and mobility applications. It offers aerogel insulation blankets and engineered thermal barrier products (including Pyrogel, Cryogel and PyroThin) and pursues carbon aerogel battery materials and related fabrication services. Its core businesses are organized into two reportable segments: Energy Industrial (industrial and sustainable insulation) and Thermal Barrier (EV and energy storage thermal protection and battery material initiatives). The company serves global energy industrial and EV markets through a direct sales force, distributors, contractors and OEM partnerships across North America, Europe, Asia and other regions.
Summary from filing dated 2025-02-27
Financials
Consolidated Statement of Income
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Revenue | 271 | 453 | 239 | 180 | 122 | |
| Cost of revenue | 225 | 270 | 182 | 175 | 112 | |
| Gross profit | 46 | 183 | 57 | 5 | 10 | |
| Research and development | 13 | 18 | 16 | 17 | 11 | |
| Sales and marketing | 28 | 36 | 33 | 29 | 17 | |
| General and administrative | 56 | 71 | 57 | 38 | 23 | |
| Restructuring and demobilization costs | 18 | — | — | — | — | |
| Loss on disposal of property, plant and equipment | 18 | — | — | — | — | |
| Impairment of property, plant and equipment | 291 | 4 | — | — | — | |
| Total operating expenses | 424 | 128 | 106 | 84 | 51 | |
| Income (loss) from operations | −378 | 55 | −49 | −79 | −41 | |
| Interest expense, convertible note - related party | — | −8 | −5 | −5 | — | |
| Interest income (expense), net | −11 | −4 | 7 | 2 | −229,000 | |
| Income from Employee Retention Credits | — | — | 2 | — | — | |
| Loss on extinguishment of debt | — | −27 | — | — | 4 | |
| Other income | 2 | — | — | — | — | |
| Total other income (expense) | −9 | −39 | 3 | −3 | 4 | |
| Income (loss) before income tax expense | −387 | 15 | −46 | −83 | — | |
| Income tax expense | −2 | −2 | 0 | 0 | — | |
| Net income (loss) | −390 | 13 | −46 | −83 | −37 | |
| Basic (per share) | −4.73 | 0.17 | −0.66 | −2.1 | −1.22 | |
| Diluted (per share) | −4.73 | 0.17 | −0.66 | −2.1 | −1.22 | |
| Basic (shares) | 82 | 78 | 69 | 39 | 30 | |
| Diluted (shares) | 82 | 80 | 69 | 39 | 30 |
Consolidated Balance Sheet
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Cash and cash equivalents | 157 | 221 | 140 | 281 | 77 | |
| Restricted cash | 2 | 394,000 | 248,000 | 1 | — | |
| Accounts receivable, net of allowances of $4,172 and $1,265 | 35 | 109 | 70 | 57 | 20 | |
| Inventories | 38 | 48 | 39 | 23 | 12 | |
| Prepaid expenses and other current assets | 10 | 32 | 17 | 7 | 3 | |
| Total current assets | 242 | 409 | 266 | 370 | 112 | |
| Property, plant and equipment, net | 98 | 459 | 417 | 259 | 56 | |
| Assets held for sale | 33 | — | — | — | — | |
| Operating lease right-of-use assets | 18 | 21 | 17 | 12 | 14 | |
| Finance lease right-of-use assets | 6 | — | — | — | — | |
| Other long-term assets | 9 | 6 | 2 | 3 | 1 | |
| Total assets | 407 | 895 | 703 | 643 | 183 | |
| Accounts payable | 13 | 44 | 51 | 55 | 17 | |
| Accrued expenses | 13 | 36 | 23 | 16 | 11 | |
| Deferred revenue | 1 | 2 | 2 | 6 | 1 | |
| Finance obligation for sale and leaseback transactions | 4 | 4 | — | — | — | |
| Operating lease liabilities | 3 | 3 | 2 | 2 | 2 | |
| Finance lease liabilities | 2 | — | — | — | — | |
| Long term debt - current portion | 25 | 20 | — | — | — | |
| Total current liabilities | 62 | 110 | 78 | 79 | 37 | |
| Revolving line of credit | 14 | 42 | — | — | — | |
| Long term debt | 65 | 95 | — | — | — | |
| Finance obligation for sale and leaseback transactions long-term | 5 | 10 | — | — | — | |
| Operating lease liabilities long-term | 21 | 23 | 22 | 13 | 13 | |
| Finance lease liabilities long-term | 3 | — | — | — | — | |
| Total liabilities | 171 | 280 | 215 | 196 | 55 | |
| Commitments and contingencies (Note 12) | — | — | — | — | — | |
| Preferred stock, $0.00001 par value; 5,000,000 shares authorized, no shares issued or outstanding at December 31, 2025 and 2024 | — | — | — | — | — | |
| Common stock, $0.00001 par value; 250,000,000 shares authorized, 82,711,351 and 82,040,468 shares issued and outstanding at December 31, 2025 and December 31, 2024, respectively | 0 | 0 | 0 | 0 | 0 | |
| Additional paid-in capital | 1,285 | 1,275 | 1,162 | 1,075 | 673 | |
| Accumulated deficit | −1,050 | −660 | −674 | −628 | −545 | |
| Total stockholders' equity | 236 | 615 | 488 | 447 | 128 | |
| Total liabilities and stockholders' equity | 407 | 895 | 703 | 643 | 183 |
Consolidated Statement of Cash Flows
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Net income (loss) | −390 | 13 | −46 | −83 | −37 | |
| Depreciation | 45 | 23 | 15 | 9 | 9 | |
| Accretion of interest on convertible note - related party | — | 7 | 4 | 5 | — | |
| Amortization of convertible note issuance costs | — | 24,000 | 37,000 | 32,000 | — | |
| Amortization of debt issuance costs | 4 | 1 | — | — | 18,000 | |
| Amortization of debt discount due to modification of convertible note - related party | — | 443,000 | 888,000 | — | — | |
| Deferred financing costs written off | — | 2 | — | — | — | |
| Provision for bad debt | 4 | 200,000 | −93,000 | 100,000 | −85,000 | |
| Stock-based compensation expense | 9 | 13 | 11 | — | — | |
| Impairment of property, plant and equipment | 292 | 8 | 0 | — | — | |
| Loss on disposal of property, plant and equipment | 18 | — | — | — | — | |
| Deferred taxes | −416,000 | — | — | — | — | |
| Reduction in the carrying amount of operating lease right-of-use assets | 4 | 2 | 3 | 3 | 2 | |
| Accounts receivable | 70 | −39 | −13 | −37 | −5 | |
| Inventories | 9 | −8 | −17 | −11 | 1 | |
| Prepaid expenses and other assets | 18 | −20 | −7 | −3 | −2 | |
| Accounts payable | −19 | 7 | 5 | 5 | 7 | |
| Accrued expenses | −23 | 12 | 7 | 5 | 7 | |
| Deferred revenue | −940,000 | −117,000 | −4 | 5 | −543,000 | |
| Operating lease and other liabilities | −6 | −2 | −2 | — | — | |
| Net cash provided by (used in) operating activities | 33 | 46 | −43 | −94 | −19 | |
| Capital expenditures | −37 | −86 | −175 | −178 | −14 | |
| Net cash used in investing activities | −37 | −86 | −175 | −178 | −14 | |
| Proceeds from employee stock option exercises | 2 | 10 | 2 | 553,000 | 2 | |
| Payments made for employee restricted stock tax withholdings | −765,000 | −1 | −420,000 | −2 | −3 | |
| Fees and issuance costs from registered direct offering of common stock | −28,000 | −686,000 | −623,000 | — | — | |
| Proceeds from employee stock purchase plan | 176,000 | — | — | — | — | |
| Fees and issuance costs from private placement of common stock | — | — | −139,000 | −137,000 | −1 | |
| Repayment of convertible note | — | −150 | — | — | — | |
| Repayment of term loan | −26 | −7 | — | — | — | |
| Proceeds from term loan | — | 125 | — | — | — | |
| Issuance costs from term loan and revolving line of credit | — | −6 | — | — | — | |
| Proceeds from revolving line of credit | — | 43 | — | — | — | |
| Repayment of revolving line of credit | −28 | — | — | — | — | |
| Proceeds from sale and leaseback transactions | — | 15 | — | — | — | |
| Repayment of lease and other finance obligations | −5 | −868,000 | — | — | — | |
| Net cash (used in) provided by financing activities | −58 | 122 | 75 | 478 | 92 | |
| Net (decrease) increase in cash, cash equivalents and restricted cash | −63 | 81 | −143 | 206 | 60 | |
| Interest paid | 12 | 7 | 1,000 | 153,000 | 236,000 | |
| Income taxes paid | 4 | — | 0 | 0 | 0 | |
| Right-of-use assets obtained in exchange for new operating lease liabilities | 24,000 | 5 | 10 | 3 | 12 | |
| Capitalized Interest | — | — | 6 | 3 | — | |
| Changes in accrued capital expenditures | −12 | −14 | −8 | 32 | 5 |